These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 3806414)
1. Mouse antithrombotic assay: the effects of Ca++ channel blockers are platelet-independent. Molinari A; Guarneri L; Pacei E; de Marchi F; Cerletti C; de Gaetano G J Pharmacol Exp Ther; 1987 Feb; 240(2):623-7. PubMed ID: 3806414 [TBL] [Abstract][Full Text] [Related]
2. Picotamide protects mice from death in a pulmonary embolism model by a mechanism independent from thromboxane suppression. Gresele P; Corona C; Alberti P; Nenci GG Thromb Haemost; 1990 Aug; 64(1):80-6. PubMed ID: 2274931 [TBL] [Abstract][Full Text] [Related]
3. The involvement of platelets and the coronary vasculature in collagen-induced sudden death in rabbits. Mallarkey G; Smith GM Thromb Haemost; 1985 Feb; 53(1):70-4. PubMed ID: 3992523 [TBL] [Abstract][Full Text] [Related]
4. Effect of calcium channel blockers on platelet GPIIb-IIIa as a calcium channel in liposomes: comparison with effects on the intact platelet. Rybak ME; Renzulli LA Thromb Haemost; 1992 Jan; 67(1):131-6. PubMed ID: 1319614 [TBL] [Abstract][Full Text] [Related]
5. Influence of calcium antagonists on platelet function and vascular prostacyclin production. Pirich C; Schmid P; Fitscha P; Wytek R; O'Grady J; Sinzinger H Blood Press Suppl; 1994; 1():75-80. PubMed ID: 8205307 [TBL] [Abstract][Full Text] [Related]
6. Differential actions of naftopidil, doxazosin and nifedipine on platelet thromboxane generation and platelet-derived growth factor efflux in vitro. Alarayyed NA; Prichard BN; Betteridge DJ; Smith CC Platelets; 2002; 13(5-6):267-71. PubMed ID: 12189011 [TBL] [Abstract][Full Text] [Related]
7. Effect of vintoperol on platelet aggregation and experimental thrombosis. Csomor K; Kárpáti E Arzneimittelforschung; 1994 Jan; 44(1):36-40. PubMed ID: 8135876 [TBL] [Abstract][Full Text] [Related]
8. Failure of aspirin to impair bovine platelet function. Gentry PA; Tremblay RR; Ross ML Am J Vet Res; 1989 Jun; 50(6):919-22. PubMed ID: 2764343 [TBL] [Abstract][Full Text] [Related]
9. A new model of pulmonary microembolism in the mouse. Guarneri L; Molinari A; Casacci F; Pacei E; Cerletti C; de Gaetano G J Pharmacol Methods; 1988 Sep; 20(2):161-7. PubMed ID: 3221679 [TBL] [Abstract][Full Text] [Related]
10. Effects of MN-9202 on platelet aggregation, 5-HT release, TXB2 synthesis, and calcium mobilization in rabbit platelets in vitro. Wang LL; Mei QB; Zhao DH; Guo ZA Acta Pharmacol Sin; 2000 Jul; 21(7):623-6. PubMed ID: 11360670 [TBL] [Abstract][Full Text] [Related]
11. In vivo anti-platelet properties of anipamil, a calcium channel blocker, in the rabbit. Osborne JA; Darius H; Lefer AM Res Commun Chem Pathol Pharmacol; 1986 May; 52(2):167-78. PubMed ID: 3715198 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of endothelial cells and calcium channel blockers on platelet aggregation. Yamada Y; Furui H; Furumichi T; Suzuki T; Yamauchi K; Yokota M; Hayashi H; Saito H Jpn Heart J; 1990 Mar; 31(2):201-15. PubMed ID: 2113109 [TBL] [Abstract][Full Text] [Related]
13. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100. Homoncik M; Jilma B; Hergovich N; Stohlawetz P; Panzer S; Speiser W Thromb Haemost; 2000 Feb; 83(2):316-21. PubMed ID: 10739392 [TBL] [Abstract][Full Text] [Related]
14. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists. Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the inhibitory effects of aspirin and ticlopidine on platelet aggregation and Ca2+ mobilization in rat platelets. Morikawa M; Kojima T; Inoue M; Tsuboi M Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):275-8. PubMed ID: 3024274 [TBL] [Abstract][Full Text] [Related]
16. Effects of nitrendipine and tiapamil on 45Ca2+ influx and on platelet aggregation. Kribben A; Fritschka E; Senger D; Sibold M; Distler A; Philipp T J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S68-9. PubMed ID: 2455144 [TBL] [Abstract][Full Text] [Related]
17. Blockade of glycoprotein IIb/IIIa mediates the antithrombotic activity of butanol fraction of Actinostemma lobatum Maxim. Kim KH; Lee HJ; Lee JH; Jang YS; Kim DK; Shim BS; Cho KH; Ko SG; Ahn KS; Kim SH J Ethnopharmacol; 2008 Mar; 116(3):431-8. PubMed ID: 18243609 [TBL] [Abstract][Full Text] [Related]
18. Some characteristics of mouse platelet aggregation and a comparison of the activity of a range of compounds in mouse and human platelet-rich plasma in vitro. Nunn B Thromb Haemost; 1981 Feb; 45(1):1-5. PubMed ID: 7245119 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955 [TBL] [Abstract][Full Text] [Related]
20. Antiplatelet and antithrombotic effects of YM337, the Fab fragment of a humanized anti-GPIIb/IIIa monoclonal antibody in monkeys. Kaku S; Kawasaki T; Hisamichi N; Sakai Y; Taniuchi Y; Inagaki O; Yano S; Suzuki K; Terazaki C; Masuho Y; Satoh N; Takenaka T; Yanagi K; Ohshima N Thromb Haemost; 1996 Apr; 75(4):679-84. PubMed ID: 8743199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]